v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Consolidated net income $ 15,791 $ 12,179
Loss from discontinued operations, net of tax 0 2
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss on extinguishment of debt 1,235 0
Loss on sale of property, plant, and equipment 40 1
Depreciation and other amortization expense 1,309 848
Amortization of other intangible assets 307 305
Amortization of deferred financing costs 448 696
Deferred income tax expense 1,716 114
Stock compensation expense 1,664 2,062
Noncash lease income (380) (42)
Loss on MSA investments 0 6
Changes in operating assets and liabilities:    
Accounts receivable (5,539) 1,846
Inventories (8,310) (7,488)
Other current assets (5,399) 1,050
Other assets (1,418) (270)
Accounts payable 15,433 10,800
Accrued liabilities and other 512 (2,933)
Operating cash flows from continuing operations 17,409 19,176
Operating cash flows from discontinued operations 0 3,463
Net cash provided by operating activities 17,409 22,639
Cash flows from investing activities:    
Capital expenditures (2,185) (366)
Payment for equity investments (2,783)
Purchases of investments (714) (7,119)
Proceeds from sale of investments 500 0
Purchases of non-marketable equity investments 0 (500)
MSA escrow deposits, net (48) (1)
Investing cash flows from continuing operations (5,230) (7,986)
Investing cash flows from discontinued operations 0 0
Net cash used in investing activities (5,230) (7,986)
Cash flows from financing activities:    
Redemption of 2026 Notes (250,000) 0
Proceeds from 2032 Notes 300,000 0
Payment of dividends (1,385) (1,149)
Payment of financing costs (6,582) 0
Exercise of options 973 3
Redemption of options (33) 0
Redemption of restricted stock units (1,828) (136)
Redemption of performance based restricted stock units (2,625) (1,212)
Common stock repurchased 0 (2,079)
Financing cash flows from continuing operations 38,520 (4,573)
Financing cash flows from discontinued operations 0 0
Net cash provided by (used in) financing activities 38,520 (4,573)
Net increase in cash 50,699 10,080
Effect of foreign currency translation on cash (48) (58)
Unrestricted 48,941 117,886
Restricted 1,961 4,929
Total cash at beginning of period 50,902 122,815
Unrestricted 99,640 130,903
Restricted 1,913 1,934
Total cash at end of period 101,553 132,837
Supplemental schedule of noncash investing activities:    
Accrued capital expenditures 0 10
Investment acquired in exchange for net assets held for sale 10,496 0
Supplemental schedule of noncash financing activities:    
Dividends declared not paid $ 1,377 $ 1,261